LON:TRX Tissue Regenix Group (TRX) Share Price, News & Analysis GBX 0.07 0.00 (0.00%) As of 01/6/2026 Add Compare Share Share Stock Analysis Stock AnalysisChartBuy This Stock About Tissue Regenix Group Stock (LON:TRX) Get Tissue Regenix Group alerts:Sign Up Key Stats Today's Range 0.07▼ 0.0750-Day Range 0.07▼ 0.0752-Week Range 4.77▼ 66VolumeN/AAverage Volume169,613 shsMarket Capitalization£51.65 thousandP/E RatioN/ADividend Yield4.12%Price TargetN/AConsensus RatingN/A Company Overview Tissue Regenix is a leading medical device company in regenerative medicine. The Company's patented decellularisation technology (dCELL®) removes DNA and other cellular material from animal and human soft tissue, leaving an acellular tissue scaffold not rejected by the patient's body that can be used to repair diseased or damaged body structures. Current applications address many crucial clinical needs in sports medicine, foot and ankle injuries, and wound care. In August 2017, Tissue Regenix acquired CellRight Technologies®. This biotech company specialises in regenerative medicine and is dedicated to developing high-quality, innovative tissue scaffolds to enhance healing opportunities in defects created by trauma and disease. CellRight's human tissue products may be used in spine, trauma, general orthopaedic, dental and ophthalmological surgical procedures. Read More Receive TRX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Tissue Regenix Group and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. TRX Stock News HeadlinesTissue Regenix Group PLCApril 22, 2026 | marketwatch.comCellRight Tech: Private Equity Funding SecuredJanuary 8, 2026 | finance.yahoo.comIran's New Leader Just Said Something That Should Terrify Every AmericanIran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of the world's oil passing through that corridor, crude has already crossed $100 per barrel. History shows gold surged 571% during the 1973 oil crisis and 425% in 1979. Today, the U.S. holds 8,133 tonnes of gold valued on the books at $42.22 per ounce - while gold trades above $5,000. American Alternative Assets has released The Great Gold Reset report detailing what this gap could mean for investors. | American Alternative (Ad)CellRight Technologies, LLC Announces Update and Senior Leadership ChangesOctober 21, 2025 | finance.yahoo.comTissue Regenix Group PLC (LSE:TRX) Full Year 2024 Earnings Call Highlights: Record Profit and ...July 3, 2025 | finance.yahoo.comTissue Regenix Scraps Sale Plans, Flags Profit AheadApril 8, 2025 | marketwatch.comTissue Regenix Group Regulatory NewsFebruary 18, 2025 | lse.co.ukTissue Regenix Group Share Chat (TRX)November 3, 2024 | lse.co.ukSee More Headlines TRX Stock Analysis - Frequently Asked Questions How have TRX shares performed this year? Tissue Regenix Group's stock was trading at GBX 0.07 at the beginning of 2026. Since then, TRX stock has increased by 0.0% and is now trading at GBX 0.07. How were Tissue Regenix Group's earnings last quarter? Tissue Regenix Group plc (LON:TRX) issued its quarterly earnings results on Wednesday, September, 2nd. The company reported ($0.16) earnings per share (EPS) for the quarter. Tissue Regenix Group had a negative trailing twelve-month return on equity of 3.16% and a negative net margin of 6.77%. How do I buy shares of Tissue Regenix Group? Shares of TRX stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What other stocks do shareholders of Tissue Regenix Group own? Based on aggregate information from My MarketBeat watchlists, some other companies that Tissue Regenix Group investors own include Lloyds Banking Group (LLOY), Argos Therapeutics (ARGSQ), FuelCell Energy (FCEL), TransEnterix (TRXDW), Swedbank (SWDBY), Trevena (TRVN) and Barrick Gold (ABX). Company Calendar Last Earnings9/02/2020Today5/13/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Biotechnology Sub-IndustryPrecious Metals Current SymbolLON:TRX CIKN/A Webwww.tissueregenix.com Phone+44-1904-567609FaxN/AEmployees120Year FoundedN/AProfitability EPS (Trailing Twelve Months)GBX (1.91) Trailing P/E RatioN/A Forward P/E Ratio0.14 P/E GrowthN/ANet Income-£1.11 million Net Margins-6.77% Pretax MarginN/A Return on Equity-3.16% Return on Assets0.50% Debt Debt-to-Equity Ratio37.46 Current Ratio2.88 Quick Ratio2.36 Sales & Book Value Annual Sales£27.75 million Price / Sales0.00 Cash FlowGBX 0.01 per share Price / Cash Flow5.70 Book ValueGBX 41.58 per share Price / Book0.00Miscellaneous Outstanding Shares71,235,000Free FloatN/AMarket Cap£51.65 thousand OptionableNot Optionable Beta1.61 The Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Click the link to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.Get This Free Report This page (LON:TRX) was last updated on 5/14/2026 by MarketBeat.com Staff. From Our PartnersThe one number Musk can't hide in the S-1When SpaceX files its S-1 in June, one number will stand out - power consumption. Running 1 million GPUs requi...Behind the Markets | SponsoredWhy I'm NOT Buying the SpaceX IPO (And What I'm Buying Instead)The media's calling it "the biggest IPO in Wall Street history." But I'm not buying it. Institutions got into ...Decentralized Masters | SponsoredRead this or regret it foreverThree Nobel Prize Winners expose this once-in-a-generation wealth shift: “Don’t Say I Didn’t Warn You” P...Porter & Company | SponsoredTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredIran's New Leader Just Said Something That Should Terrify Every AmericanIran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...American Alternative | SponsoredBefore you buy SpaceX shares, consider this alternative approachSpaceX has confidentially filed for an IPO with the SEC, targeting a June 2026 listing at a valuation exceedin...Weiss Ratings | SponsoredCollect $1,170 a month from silverI've Rarely Seen This With Silver This combination - 20% dividends + 68% share appreciation - never happens...Investors Alley | SponsoredThe system holding the dollar together is gone…Saudi Arabia has terminated its 1974 petrodollar agreement with the United States - the deal that forced every...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tissue Regenix Group plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Tissue Regenix Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TRX Stock Alerts